Close

Hippocampal neuroinflammation causes sex-specific disruptions in action selection, food approach memories, and neuronal activation

Kiruthika Ganesan, Sahar Ghorbanpour, William Kendall, Sarah Thomas Broome, Joanne M. Gladding, Amolika Dhungana, Arvie Rodriguez Abiero, Maedeh Mahmoudi, Alessandro Castorina, Michael D. Kendig, Serena Becchi, Veronika Valova, Louise Cole, Laura A. Bradfield

Posted on: 22 November 2024 , updated on: 26 November 2024

Preprint posted on 3 September 2024

Closing the gap: insights into sex-specific effects of hippocampal neuroinflammation

Selected by Nicole Bertola

Categories: neuroscience

Introduction

Just as ancient civilizations once believed Earth was the center of our solar system, so the male body has been the referential point in the study of human anatomy (Kropp et al., 2023; Zucker et al., 2023; Szadvári et al., 2022).  For too long, female physiology was thought to be just the same, despite the evident sexual dimorphism, the presence and role of different hormones, the different chromosomes, to name but a few. Moved by modern times and a change in our thinking, more and more research groups started to also cover the female counterpart in their studies (e.g., using female mice or including women in clinical trials). In this context, I will focus on a recent study investigating hippocampal neuroinflammation from a sex-specific perspective.

Background

Alzheimer’s disease, multiple sclerosis, and depression commonly include disruption of motivated behaviour, such as the inability to carry out daily tasks like preparing meals, going to work, or engaging in social interactions, with these challenges being more pronounced in women. It has been speculated that hippocampal neuroinflammation might be the cause of this gender-specific alteration but it is not easy to understand if neuroinflammation alone is sufficient to cause such a behavioural change. In this preprint, Ganesan and colleagues try to answer this question.

Key findings

LPS induces neuronal activity in neuronal and glial cocultures

Firstly, the authors conducted in vitro studies demonstrating that the administration of lipopolysaccharide (LPS) did not alter neuronal activity (measured by cFos expression) when applied to a monoculture of hippocampal neurons. On the contrary, it significantly increased neuronal activity when administrated to neuronal/glial cocultures (particularly astrocytes). Indeed, during neuroinflammation, microglia and astrocytes are subjected to changes in function and morphology which, inevitably, also affect their neighbouring neurons.

In vivo LPS administration affects multiple aspects of motivated behaviour in consistent or sex-specific ways

After in vitro validation, the researchers injected LPS directly into the dorsal hippocampus of female and male mice performing a wide range of behavioural tests. The impact of neuroinflammation on goal-directed behaviour was measured using a classical “press levers for rewards” test. Interestingly, mice of both sexes showed an increase in goal-directed action control. Additionally, a Pavlovian approach was used to evaluate head entries into the food magazine, where rewards were delivered. The main finding was that LPS-treated females showed fewer magazine entries, while LPS-treated males showed more.

LPS treatment modifies neuronal activity in vivo

To test the possible effect of LPS on neuronal activity, in the presence of astrocytes, the authors performed immunostaining for the neuronal marker NeuN and the activity marker cFos at the level of the dorsal hippocampus. The results suggest that hippocampal neuroinflammation does indeed produce sex-specific alterations in neuronal activity; particularly in the dentate gyrus (a region crucial for learning and memory processes), increasing it in females yet decreasing it in males. This represents the potential underlying mechanism for the observed sex-specific behavioural differences.

What’s the possible mechanism behind the sex-specific response to neuroinflammation?

The presence of different sex hormones might represent a good explanation for the different behavioural outcomes in male and female mice. Indeed, estrogen has been shown to increase neuronal excitability in the hippocampus, while androgens appear to have the opposite effect, decreasing it. Estradiol (a form of estrogen) is also known to be neuroprotective reducing the number of pro-inflammatory cytokines after LPS administration, facilitating brain repair. The authors thus speculate that an interaction between microglial/astrocytic activation and estrogen (or androgens) occurred in the current study, particularly in females, that could account for the changes in behaviour and neuronal activity.

Why I picked this preprint

I found this preprint is fascinating for two main reasons: it shows that neuroinflammation alone can alter behavior without additional neuropathologies and does so in a sex-specific manner. It is one of many studies highlighting biological differences between males and females. Despite women representing the 50% of the population, medical devices, drugs, and even crash test dummies have historically been tested primarily on men, increasing women’s vulnerability. Thankfully, modern science is shifting to include women equally. To quote Simone de Beauvoir’s seminal work, women are not “the second sex”.

Questions for the authors

  • How do you think these findings would translate when using other neuroinflammation models, such as cytokine exposure or models of chronic inflammation?
  • How did you decide on the specific behavioural tests used in this study? Do you think other tasks might reveal additional sex-specific effects of neuroinflammation on motivation or cognition?
  • Given that estrogen and androgens can have such distinct effects on neuroinflammation, how might the stage of the estrous cycle or the age of the animals affect the results in females? Did you control for or consider these factors, and how might they impact the findings?
  • Given your findings, do you believe there could be sex-specific treatments for neuroinflammation-linked diseases? How feasible do you think it would be to develop therapies that take sex-specific neuronal or hormonal responses into account?

 

doi: https://doi.org/10.1242/prelights.38968

Read preprint (No Ratings Yet)

Author's response

The author team shared

How do you think these findings would translate when using other neuroinflammation models, such as cytokine exposure or models of chronic inflammation?

This is a really good question and one I’d love to test sometime. We have recent work showing that striatal neuroinflammation produces very different behavioural outcomes, so if the model is systemic it could potentially be different.

How did you decide on the specific behavioural tests used in this study? Do you think other tasks might reveal additional sex-specific effects of neuroinflammation on motivation or cognition?

This was based on our earlier work in a mouse AD model published in eNeuro where we found goal-directed actions impaired in both male and female mice with AD, which is what we expected here. We also didn’t see sex differences in the prior study so that was a surprise! I think the younger age of the mice in this study was another reason for the differences.

Yes, definitely we have some other behaviours in mind to test that I believe will reveal sex-specific differences as well. From our work, this seems especially the case when behaviour is hippocampally-dependent. Striatal-based behaviours don’t show the same sex-based differences. Here’s a shameless plug for the AD paper too;) eneuro.org/content/10/2/E

Given that estrogen and androgens can have such distinct effects on neuroinflammation, how might the stage of the estrous cycle or the age of the animals affect the results in females? Did you control for or consider these factors, and how might they impact the findings?

Given our findings I think this is very possible! We didn’t control for these factors here but perhaps should in future work.

Given your findings, do you believe there could be sex-specific treatments for neuroinflammation-linked diseases? How feasible do you think it would be to develop therapies that take sex-specific neuronal or hormonal responses into account?

I absolutely think that sex- (or gender-) specific treatments are likely to be developed in the future. In some ways we already have these with HRT during menopause and such. I would love to re-do this study in aged mice and perhaps we could even test if HRT (or whatever the mouse version of HRT is) can rescue some of the effects.

Thank you so much again for your interest and thoughtful questions! 

Have your say

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Sign up to customise the site to your preferences and to receive alerts

Register here

Also in the neuroscience category:

Platelet-derived LPA16:0 inhibits adult neurogenesis and stress resilience in anxiety disorder

Thomas Larrieu, Charline Carron, Fabio Grieco, et al.

Selected by 04 December 2024

Harvey Roweth

Neuroscience

Investigating Mechanically Activated Currents from Trigeminal Neurons of Non-Human Primates

Karen A Lindquist, Jennifer Mecklenburg, Anahit H. Hovhannisyan, et al.

Selected by 04 December 2024

Vanessa Ehlers

Neuroscience

Circadian modulation of mosquito host-seeking persistence by Pigment-Dispersing Factor impacts daily biting patterns

Linhan Dong, Richard Hormigo, Jord M. Barnett, et al.

Selected by 29 November 2024

Javier Cavieres

Neuroscience

preLists in the neuroscience category:

2024 Hypothalamus GRC

This 2024 Hypothalamus GRC (Gordon Research Conference) preList offers an overview of cutting-edge research focused on the hypothalamus, a critical brain region involved in regulating homeostasis, behavior, and neuroendocrine functions. The studies included cover a range of topics, including neural circuits, molecular mechanisms, and the role of the hypothalamus in health and disease. This collection highlights some of the latest advances in understanding hypothalamic function, with potential implications for treating disorders such as obesity, stress, and metabolic diseases.

 



List by Nathalie Krauth

‘In preprints’ from Development 2022-2023

A list of the preprints featured in Development's 'In preprints' articles between 2022-2023

 



List by Alex Eve, Katherine Brown

CSHL 87th Symposium: Stem Cells

Preprints mentioned by speakers at the #CSHLsymp23

 



List by Alex Eve

Journal of Cell Science meeting ‘Imaging Cell Dynamics’

This preList highlights the preprints discussed at the JCS meeting 'Imaging Cell Dynamics'. The meeting was held from 14 - 17 May 2023 in Lisbon, Portugal and was organised by Erika Holzbaur, Jennifer Lippincott-Schwartz, Rob Parton and Michael Way.

 



List by Helen Zenner

FENS 2020

A collection of preprints presented during the virtual meeting of the Federation of European Neuroscience Societies (FENS) in 2020

 



List by Ana Dorrego-Rivas

ASCB EMBO Annual Meeting 2019

A collection of preprints presented at the 2019 ASCB EMBO Meeting in Washington, DC (December 7-11)

 



List by Madhuja Samaddar et al.

SDB 78th Annual Meeting 2019

A curation of the preprints presented at the SDB meeting in Boston, July 26-30 2019. The preList will be updated throughout the duration of the meeting.

 



List by Alex Eve

Autophagy

Preprints on autophagy and lysosomal degradation and its role in neurodegeneration and disease. Includes molecular mechanisms, upstream signalling and regulation as well as studies on pharmaceutical interventions to upregulate the process.

 



List by Sandra Malmgren Hill

Young Embryologist Network Conference 2019

Preprints presented at the Young Embryologist Network 2019 conference, 13 May, The Francis Crick Institute, London

 



List by Alex Eve
Close